Laura and Isaac Perlmutter Cancer Center/NYU Langone Health

New York, New York 10016

2 studies enrolling now · 5 studies all time

What they study most

Angiosarcoma, Breast Cancer, Breast Neoplasms, Breast Tumors, Colorectal Carcinoma, Early-stage Breast Cancer, Endometrial Cancer, Glioblastoma, HER2-negative Breast Cancer, HER2-positive Breast Cancer, Head and Neck Squamous Cell Carcinoma, Hormone Receptor Negative Tumor

Studies at this site

• A Study of Elacestrant Versus Standard Endocrine Therapy in Women and Men With ER+,HER2-, Early Breast Cancer With High Risk of Recurrence — Recruiting now
• I-SPY TRIAL: Neoadjuvant and Personalized Adaptive Novel Agents to Treat Breast Cancer — Recruiting now
• Study of JANX008 in Subjects With Advanced or Metastatic Solid Tumor Malignancies — Running, not enrolling
• Study of Sacituzumab Govitecan-hziy Versus Treatment of Physician's Choice in Participants With HR+/HER2- Metastatic Breast Cancer — Completed
• A Study of PRT3645 in Participants With Select Advanced or Metastatic Solid Tumors — Completed